Table 1.

Demographics, past medical history, classification of disease severity status and nosocomial infection in patients with epilepsy and COVID-19.

	Total	NS group	RS group	EH group	P
	N = 30	N = 13 (43.3%)	n = 10 (33.3%)	n = 7 (23.3%)
Age, median (IQR), y	57.5 (50.75,66.75)	56 (51.5,61.5)	59 (50.75,71.0)	62 (30.0,69.0)	0.821
Distribution
<40	2 (6.7%)	0 (0%)	0 (0%)	2 (28.6%)	0.151
40–60	12 (40.0%)	7 (53.8%)	4 (40.0%)	1 (14.3%)
>60	16 (53.3%)	6 (46.2%)	6 (60.0%)	4 (57.1%)
Gender
Male	15 (50%)	6 (46.2%)	5 (50%)	4 (57.1%)	1
Femal	15 (50%)	7 (53.8%)	5 (50%)	3 (42.9%)
Past medical history
Epilepsy	17 (56.7%)	0 (0%)	10 (100%)	7 (100%)	0
Neurological disease except for epilepsy	9 (30.0%)	1 (7.7%)*	7 (70%)	1 (14.3%)	0.005
Cerebral hemorrhage	5 (16.7%)	1 (7.7%)	4 (40%)	0 (0%)	0.094
Cerebral infarction	2 (6.7%)	0 (0%)	1 (10%)	1 (14.3%)	0.313
Brain truama	3 (10%)	0 (0%)	3 (30%)	0 (0%)	0.038
Brain tumor	1 (3.3%)	0 (0%)	1 (10%)	0 (0%)	0.567
Brain operation	2 (6.7%)	0 (0%)	2 (20%)	0 (0%)	0.152
Hypertension	13 (43.3%)	7 (53.8%)	5 (50%)	1 (14.3%)	0.237
Cardiovascular disease	2 (6.7%)	1 (7.7%)	1 (10%)	0 (0%)	1
Chronic kidney disease	3 (10%)	2 (15.4%)	1 (10%)	0 (0%)	0.776
Diabetes	4 (13.3%)	1 (7.7%)	2 (20%)	1 (14.3%)	0.801
Malignant tumor	2 (6.7%)	1 (7.7%)	0 (0%)	1 (14.3%)	0.701
No medical history	3 (10%)	3 (23.1%)	0 (0%)	0 (0%)	0.228
Disease severity status
Mild/moderate	13 (43.3%)	3 (23.1%)**	4 (40%)	6 (85.7%)	0.038
Severe/critical	17 (56.7%)	10 (76.9%)**	6 (60%)	1 (14.3%)
COVID-19 infection
Nosocomial acquired,%	12 (40%)	6 (46.2%)	4 (40%)	2 (28.6%)	0.891
Community acquired,%	18 (60%)	7 (53.8%)	6 (60%)	5 (71.4%)

NS group: New-onset seizure group without epilepsy history; RS group: recurrent seizure with epilepsy history; EH group: epilepsy history group.

P less than 0.05 was considered statistcally significant.

*Differences between NS and RS group, P < 0.05; **Differences between NS and EH group, P < 0.05.